Description
In this presentation for World CDx Europe 2024, Gema Fuerte, PhD, discusses how single-cell multi-omics can help:
- Dissect molecular heterogeneity, characterize disease-driving clones, and identify molecular mechanisms of relapse.
- Track clonal changes to measure therapeutic efficiency and changes throughout the course of disease.
- Perform predictive biomarker screening to identify responders vs non responders and improve patient stratification